I'm 90% sure that the SPRY stock history before fall 2022 is actually the stock history of Silverback Therapeutics (trading at SBTX). The two companies merged i

I'm 90% sure that the SPRY stock history before fall 2022 is actually the stock history of Silverback Therapeutics (trading at SBTX). The two companies merged in fall 2022. Silverback had raised a pile of cash to push through a cancer drug, but saw their development programs stall out due to poor results. https://www.fiercepharma.com/pharma/silverback-admits-defeat-ars-troops-forward-fund-commercialization-epinephrine-nasal-spray https://www.fiercepharma.com/pharma/silverback-admits-defeat... As for expected market size - you can look at their investor deck. Slide 29(of 33) for their projected unit sales (in probably the most awful graph I've ever seen). You can look at slide 28/33 for market share data of other newly released nasal drugs. https://ir.ars-pharma.com/static-files/a2079aad-1856-42f9-90a5-c451d002f4aa https://ir.ars-pharma.com/static-files/a2079aad-1856-42f9-90...